Real-time enrollment status for this gastric or gastroesophageal junction adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 3:58 PM UTC
| NCT Number | NCT06841679 |
| Recruiting Status | Recruiting |
| Condition | Gastric or Gastroesophageal Junction Adenocarcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 778 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Beijing Biostar Pharmaceuticals Co., Ltd. |
| Last Updated on CT.gov | November 25, 2025 (Nov 25, 2025) |
As of July 13, 2026: Clinical trial NCT06841679 is currently recruiting participants. This clinical trial study for gastric or gastroesophageal junction adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Beijing Biostar Pharmaceuticals Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06841679 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06841679 was last updated Nov 25, 2025 (November 25, 2025). HelloStudys verifies this status automatically.